Noida Sector 12

Noida Sector 11


Preet Vihar, Delhi

Pandav Nagar, Delhi






Unlocking the Potential: Exploring Immunotherapy’s Role in Brain Tumor Treatment

By Dr. Salil Mahajan in Neurosciences Brain Surgery Neuro & Spine Surgery

Jun 11, 2024

Immunotherapy has emerged as a promising treatment approach for various types of cancer, including brain tumors. This groundbreaking therapy harnesses the body’s immune system to recognize and attack cancer cells, offering new hope to patients with brain tumors. In this article, we explore the role of immunotherapy in treating brain tumors, its mechanisms of action, current challenges, and future directions.

Understanding Immunotherapy

Immunotherapy works by stimulating the body’s natural defense mechanisms to target and destroy cancer cells. Unlike traditional cancer treatments such as chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy enhances the immune system’s ability to recognize and eliminate cancerous cells while sparing healthy tissue.

Mechanisms of Action

Several immunotherapy approaches are being investigated for the treatment of brain tumors:

  1. Checkpoint Inhibitors: Checkpoint inhibitors are drugs that block inhibitory signals on immune cells, allowing them to recognize and attack cancer cells more effectively. Drugs targeting checkpoint proteins such as PD-1, PD-L1, and CTLA-4 have shown promising results in clinical trials for certain types of brain tumors.
  2. CAR-T Cell Therapy: CAR-T cell therapy involves genetically modifying a patient’s T cells to express chimeric antigen receptors (CARs) that target specific proteins on cancer cells. These engineered T cells are then infused back into the patient, where they can recognize and destroy tumor cells. CAR-T cell therapy has demonstrated encouraging outcomes in some patients with glioblastoma, a type of aggressive brain tumor.
  3. Vaccines: Cancer vaccines are designed to stimulate the immune system to recognize and attack tumor cells. Vaccines containing tumor-specific antigens can help prime the immune system to mount a targeted response against cancer cells. Several vaccine-based approaches are being explored for the treatment of brain tumors, including peptide vaccines and dendritic cell vaccines.

Current Challenges

While immunotherapy holds great promise for the treatment of brain tumors, several challenges need to be addressed:

  1. Blood-Brain Barrier: The blood-brain barrier, a protective barrier that prevents toxins and pathogens from entering the brain, can also limit the penetration of immunotherapeutic agents into brain tumors. Strategies to enhance drug delivery across the blood-brain barrier are under investigation to improve the efficacy of immunotherapy for brain tumors.
  2. Tumor Heterogeneity: Brain tumors are highly heterogeneous, meaning they contain a diverse population of cancer cells with different genetic and molecular profiles. This heterogeneity can make it challenging to develop immunotherapeutic strategies that target all cancer cells effectively.
  3. Immune Suppression: Tumors can evade the immune system by employing various mechanisms to suppress immune responses. Overcoming immune suppression within the tumor microenvironment is critical for enhancing the effectiveness of immunotherapy.

Future Directions

Despite these challenges, ongoing research efforts continue to advance the field of immunotherapy for brain tumors:

  1. Combination Therapies: Combining immunotherapy with other treatment modalities, such as chemotherapy, radiation therapy, and targeted therapies, may enhance treatment outcomes by targeting different aspects of tumor biology simultaneously.
  2. Biomarker Discovery: Identifying biomarkers that predict response to immunotherapy can help personalize treatment approaches and identify patients most likely to benefit from these therapies.
  3. Novel Immunotherapeutic Agents: The development of novel immunotherapeutic agents, including bi-specific antibodies, oncolytic viruses, and immune-modulating cytokines, holds promise for expanding the arsenal of treatment options for brain tumors.


Dr. Salil Mahajan
Consultant – Neuro & Spine Surgery
Metro Hospital and Heart Institute, Haridwar, Uttrakhand